Marchut E, Gumińska M, Kedryna T
Institute of Medical Biochemistry, N. Copernicus Medical Academy, Kraków, Poland.
Pol J Pharmacol Pharm. 1988 Mar-Apr;40(2):167-72.
The effect of buthobendin (2S,2'S isomer of N,N'-dimethyl N,N'-bis[1-(3',4',5'-trimethoxybenzoyloxy)-butyl-2]-ethylenediamin e dihydrochloride), (CravitenR) on aerobic and anaerobic glycolysis in rabbit myocardial slices was compared with that of the biologically inactive isomer 2R,2'R and the well-known antiarrhythmic drugs quinidine and procainamide. Only buthobendin stimulated lactate formation under anaerobic and aerobic conditions. However, that effect was not accompanied with a parallel increase in the glucose uptake, but was related to a decrease in the glycogen level. This finding might indicate that buthobendin stimulates glycolysis by mobilization of the glycogen degradation.
将丁霍苯定(N,N'-二甲基-N,N'-双[1-(3',4',5'-三甲氧基苯甲酰氧基)-丁基-2]-乙二胺二盐酸盐的2S,2'S异构体)(CravitenR)对兔心肌切片有氧和无氧糖酵解的作用与无生物活性的2R,2'R异构体以及著名的抗心律失常药物奎尼丁和普鲁卡因胺进行了比较。只有丁霍苯定在厌氧和好氧条件下刺激乳酸形成。然而,该作用并未伴随着葡萄糖摄取的平行增加,而是与糖原水平的降低有关。这一发现可能表明丁霍苯定通过动员糖原降解来刺激糖酵解。